Sectors
Construction company SMS joined Boehringer Ingelheim and past corporate backers including Shire, Mitsui and ATMI in backing Promethera.
Cambrian Genomics, which raised seed funding from corporate-backed Alchemist Accelerator, has raised $10m from 127 backers.
The corporate-backed fund provided seed financing for delivery service Lockbox and joined liver damage testing company Humedics' series C round.
The lung treatment developer could be bought from backers including Merck and Novo for up to $444m.
Matter launched in Chicago with $3.5m of government backing and $4.4m of private funding, supplied partly by a range of strategic corporates.
The telecommunications network has showcased four new graduates from its 39works incubator in Tokyo.
The healthcare software producer secured $15m in the GE-backed round, which followed a $30m round raised two years ago.
Legend and Novartis co-led the genome mapping company's series C round, which increased its total funding to $113m.
Mitsui and BlueCross BlueShield will both exit Change Healthcare, which is set to become Emdeon's healthcare engagement division.
Novartis participated in the series A round for Intellia, which was co-launched by biotechnology developer Caribou.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
